Refine by
In Vivo Testing Suppliers Near Botswana
22 companies found
based inPittsburgh, PENNSYLVANIA (USA)
Founded in 2012, PECA Labs, Inc. is a Carnegie Mellon University and University of Pittsburgh Spin-off Focused on the Pediatric and Cardiovascular Surgical Device Spaces. PECA Labs now has a suite of disruptive products in development, which are ...
Dedicated to Supporting the Development of Innovative Devices for Pediatrics and other Underserved ...
based inEpalinges, SWITZERLAND
Novostia is a privately held medical device company developing an innovative artificial heart valve, especially for young patients. With the support of world leading surgeons, Novostia endeavors to improve the quality of life of millions of patients ...
Your heart is the most important muscular organ in your body. It is a two-sided pump that beats about 100,000 times a day (more than 2 billion times in an average lifetime) to keep your blood circulation going. The right side of the heart pumps ...
based inLondon, UNITED KINGDOM
Hemogenyx Pharmaceuticals is developing breakthrough therapies for the treatment of blood diseases. Hemogenyx Pharmaceuticals plc is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx ...
Hemogenyx Pharmaceuticals has constructed Chimeric Antigen Receptor (CAR) programmed T cells, termed HEMO-CAR-T, for the potential treatment of Acute Myeloid Leukemia (AML). HEMO-CAR-T is made using Hemogenyx’s proprietary humanised monoclonal ...
based inPearland, TEXAS (USA)
Base Pair Biotechnologies, Inc. is a world-leading provider of highly customized aptamer discovery and development services. The company was founded in 2012. It is privately held and located in the Houston, Texas metropolitan area, close to major ...
Aptamer discovery is a complex process. Customized libraries and selection techniques are employed to achieve selective binding to a target of interest under anticipated conditions. In some cases, selected aptamers may not quite achieve the ...
based inStillwater, MINNESOTA (USA)
Vascudyne is developing, manufacturing and commercializing regenerative acellular in-vitro grown “allograft” tissue. We are visionaries and realists in the right proportions. We are after the holy grail of bringing tissue-engineered medical products ...
Synthetic vascular grafts currently used in clinic have poor long term outcomes and low patency rates. Hyperplasia, calcification, foreign body immune response, infection, and atheroma formation are commonly encountered limiting the use of synthetic ...
based inIlmenau, GERMANY
BIOVISION is specialized in development, production and distribution of absorbable and non-absorbable implants. The in-house manufacturing includes following medical areas: Orthopedics/Traumatology/Dental Surgery: Processing of absorbable polymers ...
PolyPIN is a bioresorbable bone pin from polylactide. Metal implants are normally removed in a second operation, once the bone has healed. This not only means additional expense, but is also stressful for the patient! What is more, a second stay in ...
based inFort Worth, TEXAS (USA)
With our focus on improving patient outcomes with evidence-based healing solutions, Sanara MedTech Inc. develops, markets and distributes surgical, wound care and skin care products to physicians, hospitals, clinics and all post-acute care settings. ...
ACTIGEN™ Verified Inductive Bone Matrix is a naturally derived, differentiated allograft matrix with robust handling ...
based inSan Antonio, TEXAS (USA)
Founded and under the direct leadership of our four executives, Alliance Partners, LLC (dba Alliance Spine) is a private company, that began its operations in 2010, with a commitment to provide orthopedic and neurological medical devices and ...
Promote OsteoStrip is a pliable and absorbable cancellous bone graft that also exhibits osteoconductive and osteoinductive properties. These characteristics used as a homologous tool for bone grafting in spinal fusions, non-unions, and bone ...
based inVilligen, SWITZERLAND
InterAx combines machine learning, mathematical modeling of cellular processes, and experimental methods derived from more than 10 years of fundamental research to generate high-efficacy leads for a given GPCR target. We decipher drug effects on ...
Our breakthrough platform combines systems biology, pharmacology, and artificial intelligence to accelerate the hit-to-lead process in GPCR drug discovery. InterAx is setting an industry example of how to better understand the biology of a disease ...
based inScoresby, AUSTRALIA
Wintermute Biomedical began with a decade of medical research to find solutions to drug resistant infections. Our scientists found a way to unlock the natural antimicrobial power of fatty acids which are a part of everyday foods. We are a biomedical ...
Wintermute launched the Doxall™ Sanitiser range in 2021 and has multiple other therapeutic formulations in its development pipeline. These including a Covid 19 preventative and treatment inhalant and a topical shingles therapeutic. Wintermute ...
based inNew York, NEW YORK (USA)
We are a biopharmaceutical company developing transformational therapeutics targeting serious diseases with significant unmet medical needs. Our mission is to improve patient outcomes and save lives. To achieve our mission, we seek to capitalize on ...
We are developing MRI-1867, our licensed rationally designed, orally available, dual-action, hybrid, small molecule that is an inverse agonist of the CB1 receptor, as well as an inhibitor of the iNOS ...
based inBangalore, INDIA
Cellworks’ mission is to serve patients through advances in personalized medicine that significantly improve treatment success. We achieve better outcomes by predicting a successful match between patients and drug therapies – their Therapy Response ...
based inShirley, NEW YORK (USA)
CD Bioparticles is an established drug delivery company which provides customized solutions for developing and producing new, biocompatible drug delivery systems. We specialize in a range of formulation and drug delivery technologies, from ...
based inSão Paulo, BRAZIL
Celluris is the first company in Latin America to develop personalized treatment for cancer patients through CAR-T immunotherapy. This technique is based on the modification of the patient’s own cells into recognizing the tumor as a target, fighting ...
The Celluris’ novel solution, named RfuCAR, was engineering in order to respond some challenges addressed by clinical trials around the world. RfuCAR is a bispecific in tandem receptor CAR, that is composed by an antigen binding domain and ...
based inLancaster, CALIFORNIA (USA)
Simulations Plus provides cutting-edge software solutions and consulting services designed to enhance drug discovery, clinical development, and regulatory submission processes. With over 25 years of experience, the company has established itself as ...
GastroPlus is a simulation software designed for detailed mechanistic modeling of drug absorption across various administration routes including intravenous, oral, ocular, inhalation, dermal, subcutaneous, and intramuscular delivery. It is utilized ...
based inEpalinges, SWITZERLAND
AC BioScience Ltd., a clinical-stage biotech company and a developer of immune modulating and angiogenic cancer therapies. AC BioScience LTD. is a Swiss biotech company, pioneering the development of novel therapies in immuno-oncology and tumor ...
based inFrisco, TEXAS (USA)
4WEB Medical is an implant device company founded in 2008 in Dallas, Texas. Thirty years of research in topological dimension theory led to the discovery of a novel geometry, the 4WEB, that can be used as a building block to create high-strength, ...
based inCrosne, FRANCE
MEGA BIOPHARMA is a French player in marine biotechnology, a pioneer in the development of Bionacre. This natural biomaterial extracted from mother-of-pearl has yielded scientifically proven results in terms in the domains of bone and skin repair. ...
based inVerona, ITALY
At Sibylla Biotech, we face the complexity of drug discovery with the power of an innovative approach for meeting unmet medical needs. Born out of a scientific challenge, the PPI-FIT protocol (Pharmacological Protein Inactivation by Folding ...
In Silico: Identifying small molecules able to revolutionize drug discovery. The PPI-FIT technology allows the exploration of unique pharmacological targets represented by protein folding intermediates. This places Sibylla Biotech in the exclusive ...
based inStafford, VIRGINIA (USA)
We are Hyper-accelerate drug and medical device development. Computational models and AI allow to dramatically accelerate the development of new drugs and medical devices, to reduce, refine and replace tests on animals and clinical trials, to ...